Aclarubicin

DB11617InvestigationalSmall molecule

Aclarubicin: Overview.

Chemical structure of Aclarubicin
Formula / weight
C42H53NO15 · 811.878 g/mol (avg)
Also known as
Aclacinomycin A
Code names
NSC-208734

Resolves to

Compound
UNII74KXF8I502CAS57576-44-0ChEMBLCHEMBL502620ChEBI74619PubChem451415KEGGD02756
Clinical / RWD
RxNorm239ATCL01DB04
Structure
InChIKeyUSZYSDMBJDPRIF-SVEJIMAYSA-NSMILESCC[C@@]1(O)C[C@H](O[C@H]2C[C@@H]([C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)N(C)C)C2=C(O)C3=C(C=C2[C@H]1C(=O)OC)C(=O)C1=C(C(O)=CC=C1)C3=O
Targets
Q02880TOP2BP11388TOP2A

What you can answer from here — as of September 13, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
41Drug interactionsStructured to mechanism, not free text
Sign in
19Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1ATC codeIncluding every combination product, plus 13 drug categories
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Aclarubicin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In